Purchase Order W9114F22P0002
- Not listed
- The Defense Health Agency awarded a $714.7K firm fixed-price purchase order to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and laboratory consumables, for blood coagulation testing supplies and support services. This contract, which commenced on October 1, 2020, and extends through September 30, 2025, involves the delivery of two fully automated benchtop coagulation analyzer systems capable of performing comprehensive assays including...
- The Defense Health Agency awarded a $430,739.50 purchase order to Werfen USA LLC on October 1, 2024, for reagents and coagulation analyzer cost-per-test services. The contract, structured as a firm fixed-price procurement with no set-aside designation, will be performed in Bedford, Massachusetts and is scheduled for completion by September 30, 2029. Werfen USA LLC, a Bedford-based manufacturer of in vitro diagnostic equipment and laboratory reagents, will deliver coagulation testing...
- The Defense Health Agency awarded Werfen USA LLC a $362,185.95 firm fixed-price purchase order on September 1, 2024, for a Cost Per Reportable (CPR) automated coagulation system at David Grant Medical Center, Travis Air Force Base, California. The contract runs through August 31, 2029, with a base year from September 1, 2024, through August 31, 2025, followed by four 12-month option years. Under this solicitation, Werfen USA LLC will provide two fully automated, discrete, random access...
- The Defense Health Agency awarded Werfen USA LLC a $686,054.81 firm fixed-price purchase order for coagulation testing services and supplies at Fort Liberty, North Carolina. The award, announced on August 17, 2020, follows the Army Medical Command's solicitation for reagents and automated analyzers to support ongoing coagulation testing requirements at the installation. Under the contract, Werfen USA LLC is responsible for providing all necessary personnel, equipment, maintenance,...
- <p>This contract was awarded by the Defense Health Agency, a defense agency, to Werfen GMBH, a for-profit organization based in Germany. The contract is for a D-DIMER REPORTABLE TEST PERFORMED, with a ceiling value of $1,831.16 and a firm fixed price. The contract does not have a set-aside designation and was awarded on July 3, 2024, with an ultimate completion date of July 30, 2024. The contract is a purchase order and does not appear to be associated with a larger contract vehicle.</p>
- The Defense Health Agency awarded a firm fixed-price purchase order valued at $919,544.70 to Meditrade Medical Trading GMBH, a Germany-based medical supplier, for laboratory testing supplies supporting the Landstuhl Regional Medical Center in Germany. The contract, which was awarded on December 8, 2022, with an ultimate completion date of November 30, 2025, encompasses COVID-19 SARS-CoV-2, Chlamydia trachomatis/Neisseria gonorrhoeae (CT/GC), and Human Papilloma Virus (HPV) testing supplies....
- The Defense Health Agency awarded a $143,494.12 firm fixed-price purchase order to Diagnostica Stago Inc. for coagulation testing lab analyzers and reagents, with an ultimate completion date of July 31, 2026. The contract, awarded October 1, 2024, involves no set-aside designation and will be performed at the contractor's facility in Parsippany, New Jersey. Diagnostica Stago Inc., a foreign-owned medical device manufacturer specializing in hemostasis and thrombosis testing technologies, will...
- The Defense Health Agency awarded a $1.07M delivery order to Beckman Coulter Gesellschaft MIT Beschraenkter Haftung for equipment and supplies supporting a Total Laboratory Automation System at Landstuhl Regional Medical Center in Germany. This firm fixed-price contract, awarded October 1, 2024, with completion targeted for September 30, 2025, encompasses clinical chemistry, immunochemistry, hematology, coagulation, and serology testing capabilities. The award carries no set-aside designation...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The $176,529.60 contract is for the lease of ACL ELITE laboratory analyzers and does not have a set-aside designation. Werfen has provided similar diagnostic equipment, consumables, and support services to the Department of Veterans Affairs, Indian Health Service, National Institutes of Health, and military services under...
- The Defense Health Agency awarded a $164,970.27 firm fixed-price purchase order to Biomerieux Deutschland GMBH on May 1, 2025, for the provision of microbiology identification and antimicrobial susceptibility testing (ID/AST) analyzer equipment and supplies to support the Landstuhl Regional Medical Center (LRMC) in Germany. The contract encompasses a 53-month performance period consisting of a five-month base period (May 1 – September 30, 2025) covering 1,616 tests, followed by four one-year...
The Defense Health Agency awarded a $350,670.94 firm-fixed-price purchase order to Werfen GMBH for coagulation testing materials and services at Landstuhl Regional Medical Center in Germany. The contract, awarded December 1, 2021, extends through November 30, 2026, and supports diagnostic testing to rule out deep vein thrombosis and pulmonary embolism in patient populations. The solicitation, posted in August 2021, sought vendors capable of providing equipment, supplies, maintenance, repair services, and reagents for approximately 6,550 annual tests encompassing prothrombin time, activated partial thromboplastin time, fibrinogen, and D-dimer testing. The contract structure includes a base period from December 1, 2021 through November 30, 2022, with four one-year option periods. No set-aside designation was used in this award. Evaluation was conducted using lowest-price technically acceptable criteria, requiring vendors to demonstrate technical capability for installation, validation, training, and ongoing maintenance support. As a purchase order, this contract provides direct procurement authority for the medical center's coagulation testing requirements, supporting the Defense Health Agency's mission to deliver healthcare services to the military community stationed in Germany. The firm-fixed-price structure establishes predictable costs for the government while incentivizing contractor efficiency in delivering the specified diagnostic materials and services.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
OCONUS Coagulation Equipment & Supplies for Reportable Tests for the Landstuhl Regonal Medical Center, Germany | W9114F21Q0121 | Department of the Army Medical Command | Solicitation 1/2 | 8/17/21, 11:57 AM | |
OCONUS Coagulation Equipment & Supplies for Reportable Tests for the Landstuhl Regional Medical Center, Germany | W9114F22P0002 | Department of the Army Medical Command | Award Notice 2/2 | 11/9/21, 5:37 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00005 | Exercise an Option | $67.8k | 11/12/24 | |
| P00004 | Other Administrative Action | $0 | 8/23/24 | |
| P00003 | Funding Only Action | $64.0k | 12/6/23 | |
| P00002 | Exercise an Option | $0 | 11/16/23 | |
| P00001 | Exercise an Option | $74.7k | 11/2/22 |